“Relative symmetry with electronegativity of different key-groups” strategy for MRGPRX2 antagonist design and its effect on antigen-induced pulmonary inflammation

MRGPRX2 antagonists possess the potential for the treatment of allergic rhinitis, atopic dermatitis, and chronic urticaria. Previously, we identified a class of diaryl urea (DPU) MRGPRX2 antagonists with sub-micromolar IC50 values in vitro. However, the structure–activity relationship remains unclea...

Full description

Saved in:
Bibliographic Details
Main Authors: Jiayu Lu, Zhaomin Xia, Yongjing Zhang, He Wang, Wen Yang, Siqi Wang, Nan Wang, Yun Liu, Huaizhen He, Cheng Wang, Langchong He
Format: Article
Language:English
Published: Elsevier 2025-01-01
Series:Acta Pharmaceutica Sinica B
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2211383524004568
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849721600428998656
author Jiayu Lu
Zhaomin Xia
Yongjing Zhang
He Wang
Wen Yang
Siqi Wang
Nan Wang
Yun Liu
Huaizhen He
Cheng Wang
Langchong He
author_facet Jiayu Lu
Zhaomin Xia
Yongjing Zhang
He Wang
Wen Yang
Siqi Wang
Nan Wang
Yun Liu
Huaizhen He
Cheng Wang
Langchong He
author_sort Jiayu Lu
collection DOAJ
description MRGPRX2 antagonists possess the potential for the treatment of allergic rhinitis, atopic dermatitis, and chronic urticaria. Previously, we identified a class of diaryl urea (DPU) MRGPRX2 antagonists with sub-micromolar IC50 values in vitro. However, the structure–activity relationship remains unclear. Herein, we adopted a “relative symmetry with electronegativity of different key-groups” strategy for further modification of DPUs to achieve a promising MRGPRX2 antagonist with higher activity and safety. Electrostatic potential energy analysis and biological evaluation revealed that B-1023 and B-5023, that possess relatively symmetric electron-withdrawing substituents, remarkable inhibited mast cell degranulation at a sub-micromolar IC50 in vitro and alleviated anaphylactic symptoms. Furthermore, B-1023, mitigated antigen-induced pulmonary inflammation (AIPI) in mice and competitively bonded to MRGPRX2. In summary, the “relative symmetry with electronegativity of different key-groups” strategy provided a drug design pattern for MRGPRX2 antagonists and identified promising antiallergic precursors for AIPI treatment.
format Article
id doaj-art-15b655a5b77e470384c877bc2af36cb6
institution DOAJ
issn 2211-3835
language English
publishDate 2025-01-01
publisher Elsevier
record_format Article
series Acta Pharmaceutica Sinica B
spelling doaj-art-15b655a5b77e470384c877bc2af36cb62025-08-20T03:11:37ZengElsevierActa Pharmaceutica Sinica B2211-38352025-01-0115149450710.1016/j.apsb.2024.11.023“Relative symmetry with electronegativity of different key-groups” strategy for MRGPRX2 antagonist design and its effect on antigen-induced pulmonary inflammationJiayu Lu0Zhaomin Xia1Yongjing Zhang2He Wang3Wen Yang4Siqi Wang5Nan Wang6Yun Liu7Huaizhen He8Cheng Wang9Langchong He10School of Pharmacy, Health Science Center, Xi'an Jiaotong University, Xi'an 710061, ChinaSchool of Pharmacy, Health Science Center, Xi'an Jiaotong University, Xi'an 710061, ChinaSchool of Pharmacy, Health Science Center, Xi'an Jiaotong University, Xi'an 710061, ChinaKey Laboratory of Synthetic and Natural Functional Molecule Chemistry (Ministry of Education), College of Chemistry and Materials Science, Northwest University, Xi'an 710069, ChinaSchool of Pharmacy, Health Science Center, Xi'an Jiaotong University, Xi'an 710061, ChinaSchool of Pharmacy, Health Science Center, Xi'an Jiaotong University, Xi'an 710061, ChinaSchool of Pharmacy, Health Science Center, Xi'an Jiaotong University, Xi'an 710061, ChinaDepartment of Respiratory and Critical Care Medicine, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an 710004, ChinaSchool of Pharmacy, Health Science Center, Xi'an Jiaotong University, Xi'an 710061, ChinaSchool of Pharmacy, Health Science Center, Xi'an Jiaotong University, Xi'an 710061, China; Corresponding authors.School of Pharmacy, Health Science Center, Xi'an Jiaotong University, Xi'an 710061, China; Corresponding authors.MRGPRX2 antagonists possess the potential for the treatment of allergic rhinitis, atopic dermatitis, and chronic urticaria. Previously, we identified a class of diaryl urea (DPU) MRGPRX2 antagonists with sub-micromolar IC50 values in vitro. However, the structure–activity relationship remains unclear. Herein, we adopted a “relative symmetry with electronegativity of different key-groups” strategy for further modification of DPUs to achieve a promising MRGPRX2 antagonist with higher activity and safety. Electrostatic potential energy analysis and biological evaluation revealed that B-1023 and B-5023, that possess relatively symmetric electron-withdrawing substituents, remarkable inhibited mast cell degranulation at a sub-micromolar IC50 in vitro and alleviated anaphylactic symptoms. Furthermore, B-1023, mitigated antigen-induced pulmonary inflammation (AIPI) in mice and competitively bonded to MRGPRX2. In summary, the “relative symmetry with electronegativity of different key-groups” strategy provided a drug design pattern for MRGPRX2 antagonists and identified promising antiallergic precursors for AIPI treatment.http://www.sciencedirect.com/science/article/pii/S2211383524004568MRGPRX2AntagonistDiaryl ureaRelative symmetry with electronegativityAntiallergic activityAntigen-induced pulmonary inflammation
spellingShingle Jiayu Lu
Zhaomin Xia
Yongjing Zhang
He Wang
Wen Yang
Siqi Wang
Nan Wang
Yun Liu
Huaizhen He
Cheng Wang
Langchong He
“Relative symmetry with electronegativity of different key-groups” strategy for MRGPRX2 antagonist design and its effect on antigen-induced pulmonary inflammation
Acta Pharmaceutica Sinica B
MRGPRX2
Antagonist
Diaryl urea
Relative symmetry with electronegativity
Antiallergic activity
Antigen-induced pulmonary inflammation
title “Relative symmetry with electronegativity of different key-groups” strategy for MRGPRX2 antagonist design and its effect on antigen-induced pulmonary inflammation
title_full “Relative symmetry with electronegativity of different key-groups” strategy for MRGPRX2 antagonist design and its effect on antigen-induced pulmonary inflammation
title_fullStr “Relative symmetry with electronegativity of different key-groups” strategy for MRGPRX2 antagonist design and its effect on antigen-induced pulmonary inflammation
title_full_unstemmed “Relative symmetry with electronegativity of different key-groups” strategy for MRGPRX2 antagonist design and its effect on antigen-induced pulmonary inflammation
title_short “Relative symmetry with electronegativity of different key-groups” strategy for MRGPRX2 antagonist design and its effect on antigen-induced pulmonary inflammation
title_sort relative symmetry with electronegativity of different key groups strategy for mrgprx2 antagonist design and its effect on antigen induced pulmonary inflammation
topic MRGPRX2
Antagonist
Diaryl urea
Relative symmetry with electronegativity
Antiallergic activity
Antigen-induced pulmonary inflammation
url http://www.sciencedirect.com/science/article/pii/S2211383524004568
work_keys_str_mv AT jiayulu relativesymmetrywithelectronegativityofdifferentkeygroupsstrategyformrgprx2antagonistdesignanditseffectonantigeninducedpulmonaryinflammation
AT zhaominxia relativesymmetrywithelectronegativityofdifferentkeygroupsstrategyformrgprx2antagonistdesignanditseffectonantigeninducedpulmonaryinflammation
AT yongjingzhang relativesymmetrywithelectronegativityofdifferentkeygroupsstrategyformrgprx2antagonistdesignanditseffectonantigeninducedpulmonaryinflammation
AT hewang relativesymmetrywithelectronegativityofdifferentkeygroupsstrategyformrgprx2antagonistdesignanditseffectonantigeninducedpulmonaryinflammation
AT wenyang relativesymmetrywithelectronegativityofdifferentkeygroupsstrategyformrgprx2antagonistdesignanditseffectonantigeninducedpulmonaryinflammation
AT siqiwang relativesymmetrywithelectronegativityofdifferentkeygroupsstrategyformrgprx2antagonistdesignanditseffectonantigeninducedpulmonaryinflammation
AT nanwang relativesymmetrywithelectronegativityofdifferentkeygroupsstrategyformrgprx2antagonistdesignanditseffectonantigeninducedpulmonaryinflammation
AT yunliu relativesymmetrywithelectronegativityofdifferentkeygroupsstrategyformrgprx2antagonistdesignanditseffectonantigeninducedpulmonaryinflammation
AT huaizhenhe relativesymmetrywithelectronegativityofdifferentkeygroupsstrategyformrgprx2antagonistdesignanditseffectonantigeninducedpulmonaryinflammation
AT chengwang relativesymmetrywithelectronegativityofdifferentkeygroupsstrategyformrgprx2antagonistdesignanditseffectonantigeninducedpulmonaryinflammation
AT langchonghe relativesymmetrywithelectronegativityofdifferentkeygroupsstrategyformrgprx2antagonistdesignanditseffectonantigeninducedpulmonaryinflammation